bluebird bio (BLUE) PT Raised to $85 at Leerink Partners

December 1, 2016 11:26 AM EST Send to a Friend
Leerink Partners analyst Michael Schmidt reiterated an Outperform rating and lowered his price target on bluebird bio (NASDAQ: BLUE) to ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login